Home › Companies › CORCEPT THERAPEUTICS INC. › 2024-2025

CORCEPT THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORCEPT THERAPEUTICS INC.’s Form 8-K, filed June 16, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.

11Ballot items
366Asset managers
4,313Fund votes
June 10, 2025Meeting date

Results at a glance

Meeting of June 10, 2025: 11 items on CORCEPT THERAPEUTICS INC.’s Form 8-K, filed June 16, 2025: 9 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CORCEPT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CORCEPT THERAPEUTICS INC.

These tallies are CORCEPT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 16, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORCEPT THERAPEUTICS INC. — official shareholder meeting results, meeting held June 10, 2025
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Gregg Alton	76,656,278	--	--	738,799	14,932,062	99.0%	Elected	—
Elect Director: G. Leonard Baker, Jr.	74,929,739	--	--	2,465,338	14,932,062	97%	Elected	—
Elect Director: Joseph K. Belanoff, M.D.	77,216,259	--	--	178,818	14,932,062	99.7%	Elected	—
Elect Director: Gillian M. Cannon, Ph.D.	76,306,553	--	--	1,088,524	14,932,062	99%	Elected	—
Elect Director: David L. Mahoney	62,676,355	--	--	14,718,722	14,932,062	81%	Elected	—
Elect Director: Joshua M. Murray	76,980,464	--	--	414,613	14,932,062	99.4%	Elected	—
Elect Director: Kimberly Park	70,542,361	--	--	6,852,716	14,932,062	91%	Elected	—
Elect Director: Daniel N. Swisher, Jr.	76,564,863	--	--	830,214	14,932,062	99%	Elected	—
Elect Director: James N. Wilson	75,426,472	--	--	1,968,605	14,932,062	97%	Elected	—
2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025	90,463,359	1,488,132	375,648	--	--	98%	Approved	—
3. Compensation of named executive officers	72,914,293	4,195,859	284,923	--	14,932,064	95%	Approved	—

Source: CORCEPT THERAPEUTICS INC., Form 8-K, filed with the SEC on June 16, 2025 — read the filing on EDGAR.

How asset managers voted at the CORCEPT THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 366 asset managers that disclosed a CORCEPT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Gregg Alton

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%

FOR: 76,656,278WITHHELD: 738,799

Details: description as filed, official tally, votes by 106 asset managers

Description as filed by funds: Election of Directors: Gregg Alton

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gregg Alton”): 76,656,278 for, 738,799 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 106 asset managers below reported 32,447,503 for, 73,399 withheld, 3,398 abstained.

FOR

FOR: 32,447,503ABSTAIN: 3,398WITHHOLD: 73,399

Largest asset managers voting on “Election of Directors: Gregg Alton” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	9,835,942	1	For
BlackRock	9,461,555	0	For
Fidelity	3,532,405	0	For
State Street	1,402,794	0	For
Dimensional	1,149,353	0	For
Charles Schwab	951,545	0	For
First Trust	819,794	0	For
Legg Mason	376,374	0	For
TIAA	310,965	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	For
Equitable	223,261	0	For
Columbia Threadneedle	216,566	0	For
Janus Detroit Street Trust	200,960	0	For
Jackson National	195,479	0	For
SEI	183,783	0	For
Royce	168,550	0	For
MoA Funds Corp	155,706	0	For
Franklin Custodian Funds	150,000	0	For
Calamos	138,016	0	For
Voya	124,155	0	For
Lincoln Financial	122,192	0	For
Principal	120,434	0	For
Bridge Builder Trust	119,957	0	For
Aberdeen	114,453	0	For
American Century	110,688	0	For

Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.

2. Elect Director: Joseph K. Belanoff, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 77,216,259WITHHELD: 178,818

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: Joseph K. Belanoff, M.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joseph K. Belanoff, M.D.”): 77,216,259 for, 178,818 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,472,295 for, 14,205 withheld, 0 abstained.

FOR

FOR: 32,472,295ABSTAIN: 0WITHHOLD: 14,205

Largest asset managers voting on “Election of Directors: Joseph K. Belanoff, M.D.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Withheld	Vote
Vanguard	9,835,943	0	For
BlackRock	9,461,555	0	For
Fidelity	3,532,405	0	For
State Street	1,402,732	62	For
Dimensional	1,149,353	0	For
Charles Schwab	951,545	0	For
First Trust	819,794	0	For
Legg Mason	376,374	0	For
TIAA	310,965	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	For
Equitable	223,261	0	For
Columbia Threadneedle	216,566	0	For
Janus Detroit Street Trust	200,960	0	For
Jackson National	195,479	0	For
SEI	183,783	0	For
Royce	168,550	0	For
MoA Funds Corp	155,706	0	For
Franklin Custodian Funds	150,000	0	For
Calamos	138,016	0	For
Voya	124,155	0	For
Lincoln Financial	122,192	0	For
Principal	120,434	0	For
Bridge Builder Trust	119,957	0	For
Aberdeen	114,453	0	For
American Century	110,688	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

3. Elect Director: James N. Wilson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 75,426,472WITHHELD: 1,968,605

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: James N. Wilson

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: James N. Wilson”): 75,426,472 for, 1,968,605 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,100,915 for, 377,798 withheld, 7,787 abstained.

FOR

FOR: 32,100,915ABSTAIN: 7,787WITHHOLD: 377,798

Largest asset managers voting on “Election of Directors: James N. Wilson” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,830,871	4	5,069	For
BlackRock	9,461,555	0	0	For
Fidelity	3,532,405	0	0	For
State Street	1,402,687	0	107	For
Dimensional	1,149,353	0	0	For
Charles Schwab	951,545	0	0	For
First Trust	819,794	0	0	For
Legg Mason	376,374	0	0	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	0	For
Equitable	223,261	0	0	For
Columbia Threadneedle	0	0	216,566	Withhold
Janus Detroit Street Trust	200,960	0	0	For
Jackson National	195,479	0	0	For
SEI	183,783	0	0	For
Royce	168,550	0	0	For
MoA Funds Corp	155,706	0	0	For
Franklin Custodian Funds	150,000	0	0	For
Calamos	138,016	0	0	For
Voya	124,155	0	0	For
Lincoln Financial	122,192	0	0	For
Principal	120,434	0	0	For
Bridge Builder Trust	116,315	3,642	0	For
Aberdeen	0	0	114,453	Withhold
American Century	110,688	0	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

4. Elect Director: G. Leonard Baker, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 74,929,739WITHHELD: 2,465,338

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: G. Leonard Baker, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: G. Leonard Baker, Jr.”): 74,929,739 for, 2,465,338 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,038,262 for, 437,053 withheld, 11,184 abstained.

FOR

FOR: 32,038,262ABSTAIN: 11,184WITHHOLD: 437,053

Largest asset managers voting on “Election of Directors: G. Leonard Baker, Jr.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,830,870	4	5,069	For
BlackRock	9,461,555	0	0	For
Fidelity	3,532,405	0	0	For
State Street	1,402,687	0	107	For
Dimensional	1,149,353	0	0	For
Charles Schwab	951,545	0	0	For
First Trust	819,794	0	0	For
Legg Mason	376,374	0	0	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	0	For
Equitable	223,261	0	0	For
Columbia Threadneedle	0	0	216,566	Withhold
Janus Detroit Street Trust	200,960	0	0	For
Jackson National	195,479	0	0	For
SEI	183,783	0	0	For
Royce	168,550	0	0	For
MoA Funds Corp	155,706	0	0	For
Franklin Custodian Funds	150,000	0	0	For
Calamos	138,016	0	0	For
Voya	124,155	0	0	For
Lincoln Financial	122,192	0	0	For
Principal	120,434	0	0	For
Bridge Builder Trust	116,315	3,642	0	For
Aberdeen	0	0	114,453	Withhold
American Century	110,688	0	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

5. Elect Director: Gillian M. Cannon, Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 8 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 76,306,553WITHHELD: 1,088,524

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: Gillian M. Cannon, Ph.D.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gillian M. Cannon, Ph.D.”): 76,306,553 for, 1,088,524 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,454,460 for, 28,396 withheld, 3,644 abstained.

FOR

FOR: 32,454,460ABSTAIN: 3,644WITHHOLD: 28,396

Largest asset managers voting on “Election of Directors: Gillian M. Cannon, Ph.D.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,830,872	2	5,069	For
BlackRock	9,461,555	0	0	For
Fidelity	3,532,405	0	0	For
State Street	1,402,794	0	0	For
Dimensional	1,149,353	0	0	For
Charles Schwab	951,545	0	0	For
First Trust	819,794	0	0	For
Legg Mason	376,374	0	0	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	0	For
Equitable	223,261	0	0	For
Columbia Threadneedle	216,566	0	0	For
Janus Detroit Street Trust	200,960	0	0	For
Jackson National	195,479	0	0	For
SEI	183,783	0	0	For
Royce	168,550	0	0	For
MoA Funds Corp	155,706	0	0	For
Franklin Custodian Funds	150,000	0	0	For
Calamos	138,016	0	0	For
Voya	124,155	0	0	For
Lincoln Financial	122,192	0	0	For
Principal	120,434	0	0	For
Bridge Builder Trust	116,315	3,642	0	For
Aberdeen	114,453	0	0	For
American Century	110,688	0	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

6. Elect Director: David L. Mahoney

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD

FOR: 62,676,355WITHHELD: 14,718,722

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: David L. Mahoney

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: David L. Mahoney”): 62,676,355 for, 14,718,722 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 26,037,453 for, 5,945,364 withheld, 503,683 abstained.

FORWITHHOLD

FOR: 26,037,453ABSTAIN: 503,683WITHHOLD: 5,945,364

Largest asset managers voting on “Election of Directors: David L. Mahoney” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,825,180	25	10,738	For
BlackRock	9,461,555	0	0	For
Fidelity	1,655,895	0	1,876,510	Mixed
State Street	1,394,328	0	8,466	For
Dimensional	0	0	1,149,353	Withhold
Charles Schwab	951,545	0	0	For
First Trust	0	0	819,794	Withhold
Legg Mason	366,200	0	10,174	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	0	0	234,831	Withhold
Equitable	223,261	0	0	For
Columbia Threadneedle	216,566	0	0	For
Janus Detroit Street Trust	0	0	200,960	Withhold
Jackson National	0	195,479	0	Abstain
SEI	183,783	0	0	For
Royce	168,550	0	0	For
MoA Funds Corp	0	0	155,706	Withhold
Franklin Custodian Funds	150,000	0	0	For
Calamos	138,016	0	0	For
Voya	0	0	124,155	Withhold
Lincoln Financial	59,993	0	62,199	Mixed
Principal	29,863	0	90,571	Mixed
Bridge Builder Trust	15,837	104,120	0	Mixed
Aberdeen	0	0	114,453	Withhold
American Century	0	0	110,688	Withhold

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

7. Elect Director: Joshua M. Murray

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 76,980,464WITHHELD: 414,613

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: Joshua M. Murray

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Joshua M. Murray”): 76,980,464 for, 414,613 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 99.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,472,355 for, 14,144 withheld, 1 abstained.

FOR

FOR: 32,472,355ABSTAIN: 1WITHHOLD: 14,144

Largest asset managers voting on “Election of Directors: Joshua M. Murray” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	9,835,942	1	For
BlackRock	9,461,555	0	For
Fidelity	3,532,405	0	For
State Street	1,402,794	0	For
Dimensional	1,149,353	0	For
Charles Schwab	951,545	0	For
First Trust	819,794	0	For
Legg Mason	376,374	0	For
TIAA	310,965	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	For
Equitable	223,261	0	For
Columbia Threadneedle	216,566	0	For
Janus Detroit Street Trust	200,960	0	For
Jackson National	195,479	0	For
SEI	183,783	0	For
Royce	168,550	0	For
MoA Funds Corp	155,706	0	For
Franklin Custodian Funds	150,000	0	For
Calamos	138,016	0	For
Voya	124,155	0	For
Lincoln Financial	122,192	0	For
Principal	120,434	0	For
Bridge Builder Trust	119,957	0	For
Aberdeen	114,453	0	For
American Century	110,688	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

8. Elect Director: Kimberly Park

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%

FOR: 70,542,361WITHHELD: 6,852,716

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: Kimberly Park

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kimberly Park”): 70,542,361 for, 6,852,716 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 30,327,266 for, 2,155,155 withheld, 4,079 abstained.

FOR

FOR: 30,327,266ABSTAIN: 4,079WITHHOLD: 2,155,155

Largest asset managers voting on “Election of Directors: Kimberly Park” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Withheld	Vote
Vanguard	9,830,867	7	5,069	For
BlackRock	9,461,555	0	0	For
Fidelity	3,532,405	0	0	For
State Street	11,948	0	1,390,846	Withhold
Dimensional	1,149,353	0	0	For
Charles Schwab	951,545	0	0	For
First Trust	819,794	0	0	For
Legg Mason	376,374	0	0	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	0	For
Equitable	223,261	0	0	For
Columbia Threadneedle	0	0	216,566	Withhold
Janus Detroit Street Trust	200,960	0	0	For
Jackson National	195,479	0	0	For
SEI	0	0	183,783	Withhold
Royce	168,550	0	0	For
MoA Funds Corp	155,706	0	0	For
Franklin Custodian Funds	0	0	150,000	Withhold
Calamos	138,016	0	0	For
Voya	124,155	0	0	For
Lincoln Financial	62,199	0	59,993	Mixed
Principal	120,434	0	0	For
Bridge Builder Trust	116,315	3,642	0	For
Aberdeen	114,453	0	0	For
American Century	110,688	0	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

9. Elect Director: Daniel N. Swisher, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 76,564,863WITHHELD: 830,214

Details: description as filed, official tally, votes by 105 asset managers

Description as filed by funds: Election of Directors: Daniel N. Swisher, Jr.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel N. Swisher, Jr.”): 76,564,863 for, 830,214 withheld, per its Form 8-K filed June 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were elected to serve until the Company's 2026 annual meeting of stockholders.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 105 asset managers below reported 32,405,562 for, 73,399 withheld, 7,539 abstained.

FOR

FOR: 32,405,562ABSTAIN: 7,539WITHHOLD: 73,399

Largest asset managers voting on “Election of Directors: Daniel N. Swisher, Jr.” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	9,835,942	1	For
BlackRock	9,461,555	0	For
Fidelity	3,532,405	0	For
State Street	1,402,794	0	For
Dimensional	1,149,353	0	For
Charles Schwab	951,545	0	For
First Trust	819,794	0	For
Legg Mason	376,374	0	For
TIAA	310,965	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	For
Equitable	223,261	0	For
Columbia Threadneedle	216,566	0	For
Janus Detroit Street Trust	200,960	0	For
Jackson National	195,479	0	For
SEI	183,783	0	For
Royce	168,550	0	For
MoA Funds Corp	155,706	0	For
Franklin Custodian Funds	150,000	0	For
Calamos	138,016	0	For
Voya	124,155	0	For
Lincoln Financial	122,192	0	For
Principal	120,434	0	For
Bridge Builder Trust	119,957	0	For
Aberdeen	114,453	0	For
American Century	110,688	0	For

Showing the 25 largest of 105 asset managers. See all 105 in the interactive database.

10. 3. Compensation of named executive officers

Official result Fund totals may overlapCOMPENSATIONReported outcome: Approved

Combines 14 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%

FOR: 72,914,293AGAINST: 4,195,859

Details: description as filed, official tally, votes by 366 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“3. Compensation of named executive officers”): 72,914,293 for, 4,195,859 against — passed, per its Form 8-K filed June 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - The compensation of named executive officers was approved, on an advisory basis.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 107 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Abstain	Vote
Vanguard	9,830,867	5,076	1	For
BlackRock	9,461,555	0	0	For
Fidelity	3,532,405	0	0	For
State Street	1,402,133	661	0	For
Dimensional	1,149,353	0	0	For
Charles Schwab	951,545	0	0	For
First Trust	819,794	0	0	For
Legg Mason	376,374	0	0	For
TIAA	310,965	0	0	For
BOSTON TRUST WALDEN FUNDS	0	234,831	0	Against
Equitable	223,261	0	0	For
Columbia Threadneedle	216,566	0	0	For
Janus Detroit Street Trust	200,960	0	0	For
Jackson National	195,479	0	0	For
SEI	183,783	0	0	For
Royce	168,550	0	0	For
MoA Funds Corp	155,706	0	0	For
Franklin Custodian Funds	150,000	0	0	For
Calamos	138,016	0	0	For
Voya	124,155	0	0	For
Lincoln Financial	122,192	0	0	For
Principal	120,434	0	0	For
Bridge Builder Trust	119,957	0	0	For
Aberdeen	0	114,453	0	Against
American Century	0	110,688	0	Against

Fund voting reports, all 107 managers: 31,867,444 for, 522,301 against, 1 withheld, 51,943 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 289 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
BlackRock	3,002,757	32,145	For
State Street	2,996,227	661	For
GEODE CAPITAL MANAGEMENT, LLC	2,128,440	0	For
Fidelity	1,576,139	0	For
Renaissance	1,081,463	0	For
Charles Schwab	1,046,052	0	For
Northern Trust	692,213	0	For
JUPITER ASSET MANAGEMENT LTD	634,447	0	For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	598,685	1,221	For
Clearbridge Investments, LLC	591,311	0	For
PRINCIPAL GLOBAL INVESTORS	544,328	0	For
Apollon Wealth Management, LLC	460,000	0	For
Man Group plc	426,553	0	For
MELLON INVESTMENTS Corp	414,856	0	For
Cerity Partners LLC	397,772	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	359,814	0	For
Nuveen	318,362	0	For
PUBLIC SECTOR PENSION INVESTMENT BOARD	317,568	0	For
SEI	302,526	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	301,606	0	For
Vanguard	297,018	0	For
Dimensional	262,490	0	For
Aberdeen	0	254,832	Against
BRAUN STACEY ASSOCIATES INC	0	252,566	Against
Boston Trust Walden Co	0	252,130	Against

Institutional-manager reports, all 289 managers: 24,142,943 for, 1,813,757 against, 783 abstained, 1,097 not voted. Showing the 25 largest; see all in the interactive database.

11. 2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 90,463,359AGAINST: 1,488,132

Details: description as filed, official tally, votes by 110 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.

CORCEPT THERAPEUTICS INC.’s own tally for this item (“2. Appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 90,463,359 for, 1,488,132 against — passed, per its Form 8-K filed June 16, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - The appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 110 asset managers below reported 32,389,230 for, 123,850 against, 14,142 abstained.

FOR

FOR: 32,389,230AGAINST: 123,850ABSTAIN: 14,142

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm ” at CORCEPT THERAPEUTICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	9,830,871	5,071	For
BlackRock	9,461,555	0	For
Fidelity	3,532,405	0	For
State Street	1,402,687	107	For
Dimensional	1,149,353	0	For
Charles Schwab	951,545	0	For
First Trust	819,794	0	For
Legg Mason	376,374	0	For
TIAA	310,965	0	For
BOSTON TRUST WALDEN FUNDS	234,831	0	For
Equitable	223,261	0	For
Columbia Threadneedle	216,566	0	For
Janus Detroit Street Trust	200,960	0	For
Jackson National	195,479	0	For
SEI	183,783	0	For
Royce	168,550	0	For
MoA Funds Corp	155,706	0	For
Franklin Custodian Funds	150,000	0	For
Calamos	138,016	0	For
Voya	124,155	0	For
Lincoln Financial	122,192	0	For
Principal	120,434	0	For
Bridge Builder Trust	119,957	0	For
Aberdeen	0	114,453	Against
American Century	110,688	0	For

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.

Largest CORCEPT THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 105,113,000 shares outstanding at the time of that meeting.

Fund voting reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	9.36%
2	BlackRock	9.00%
3	Fidelity	3.36%
4	State Street	1.33%
5	Dimensional	1.09%
6	Charles Schwab	0.91%
7	First Trust	0.78%
8	Legg Mason	0.36%
9	TIAA	0.30%
10	BOSTON TRUST WALDEN FUNDS	0.22%

Institutional-manager reports: top CORCEPT THERAPEUTICS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's named executive officers as…”, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	2.89%
2	State Street	2.85%
3	GEODE CAPITAL MANAGEMENT, LLC	2.02%
4	Fidelity	1.50%
5	Renaissance	1.03%
6	Charles Schwab	1.00%
7	Northern Trust	0.66%
8	JUPITER ASSET MANAGEMENT LTD	0.60%
9	ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	0.57%
10	Clearbridge Investments, LLC	0.56%

Reported CORCEPT THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

CORCEPT THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	13.97%	13F
Vanguard Group	9.50%	13F
INGALLS & SNYDER LLC	6.91%	13G
Joseph K. Belanoff	6.49%	13G
Renaissance Technologies LLC	5.48%	13G
G. Leonard Baker, Jr.	5.28%	DEF14A
State Street	3.24%	13F
James N. Wilson	2.87%	DEF14A
Geode Capital	2.15%	13F
Dimensional Fund Advisors	2.03%	13F

Percentages above are of 105,113,000 shares outstanding, as reported by CORCEPT THERAPEUTICS INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORCEPT THERAPEUTICS INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At CORCEPT THERAPEUTICS INC.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 366 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 4,313 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — CORCEPT THERAPEUTICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CORCEPT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 16, 2025.

CORCEPT THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.